- Home
- UAN vs VALN Comparison
UAN vs VALN Comparison
Compare UAN & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAN
- VALN
- Stock Information
- Founded
- UAN 2007
- VALN 2012
- Country
- UAN United States
- VALN France
- Employees
- UAN N/A
- VALN N/A
- Industry
- UAN Agricultural Chemicals
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UAN Industrials
- VALN Health Care
- Exchange
- UAN Nasdaq
- VALN Nasdaq
- Market Cap
- UAN 1.0B
- VALN 820.0M
- IPO Year
- UAN 2011
- VALN 2021
- Fundamental
- Price
- UAN $96.05
- VALN $9.43
- Analyst Decision
- UAN
- VALN Strong Buy
- Analyst Count
- UAN 0
- VALN 4
- Target Price
- UAN N/A
- VALN $15.75
- AVG Volume (30 Days)
- UAN 87.6K
- VALN 21.9K
- Earning Date
- UAN 10-29-2025
- VALN 11-20-2025
- Dividend Yield
- UAN 7.10%
- VALN N/A
- EPS Growth
- UAN 141.96
- VALN N/A
- EPS
- UAN 12.04
- VALN N/A
- Revenue
- UAN $614,528,000.00
- VALN $211,089,992.00
- Revenue This Year
- UAN N/A
- VALN $6.86
- Revenue Next Year
- UAN N/A
- VALN $11.85
- P/E Ratio
- UAN $7.91
- VALN N/A
- Revenue Growth
- UAN 16.52
- VALN 13.48
- 52 Week Low
- UAN $63.45
- VALN $3.62
- 52 Week High
- UAN $100.89
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- UAN 46.01
- VALN 56.66
- Support Level
- UAN $94.00
- VALN $8.53
- Resistance Level
- UAN $99.16
- VALN $8.92
- Average True Range (ATR)
- UAN 2.61
- VALN 0.33
- MACD
- UAN -0.55
- VALN 0.07
- Stochastic Oscillator
- UAN 14.66
- VALN 89.57
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.